Target intelligence / Profile preview

BSN antisense RNA 2 (BSN-DT)

Target
BSN-DT
Molecular classification
Long non-coding RNA, Antisense RNA, Non-protein coding RNA
01

Overview

BSN antisense RNA 2 (BSN-DT) is a long non-coding RNA gene positioned head-to-head with the protein-coding BSN (Bassoon) gene, transcribed from the opposite strand[3]. Because BSN-DT is a non-coding antisense RNA, it is believed to have regulatory functions, possibly affecting the expression of the adjacent BSN gene, which encodes a synaptic scaffolding protein important in neurotransmitter release and has notable associations with neurological diseases[2][4]. However, direct functional or clinical relevance of BSN-DT itself has not been established, and it is not recognized as a therapeutic target or a molecule with known drug interactions based on current biomedical knowledge[3].\n\nThere are no drugs, biomarkers, or safety concerns currently associated with BSN-DT, and mechanistic information is lacking. The bulk of research and clinical interest in this genomic locus centers on the BSN protein and not its divergent non-coding transcripts.

Other names
BSN-DTBSN-AS2BSN antisense RNA 2 (head to head)BSN antisense RNA 2 (non-protein coding)
02

Biological functions

Regulation of gene expression (putative, based on lncRNA function)Possible regulation of BSN (Bassoon) gene activity (inferred from antisense position)
03

Disease associations

Not directly implicated in diseases as a causal agent; no solid evidence of direct disease associationPotential roles in regulation of neurological disease-related genes (extrapolated from locus and antisense relation)

Beyond the preview

Go deeper on BSN antisense RNA 2 (BSN-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BSN antisense RNA 2 (BSN-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call